# AstraZeneca (AZN) free cash flow: $8.67B in 2025

URL: https://funkfolio.com/stock/AZN/free-cash-flow

> AstraZeneca (AZN) free cash flow was $8.67B in fiscal 2025, up 19.2% from fiscal 2024. 4 fiscal years of history in a chart and a table.

---

## AstraZeneca (AZN) free cash flow

**Free cash flow · fiscal 2025:** $8.67B year ended Dec 31, 2025

AstraZeneca (AZN) generated free cash flow of $8.67B in fiscal 2025 (the year ended December 31, 2025). That is 19.2% higher than the $7.28B of fiscal 2024. Figures as of 18 Nov 2026, 12:25 UTC, from Yahoo Finance.

### Key facts

- **Free cash flow, fiscal 2025:** $8.67B
- **Change on fiscal 2024:** +19.2%
- **Highest on record:** $8.67B fiscal 2025
- **Lowest on record:** $6.57B fiscal 2023
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 12:25 UTC. Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

### AstraZeneca free cash flow, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $8.67B in fiscal 2025 and the lowest $6.57B in fiscal 2023.

### Free cash flow by fiscal year

### AstraZeneca free cash flow, year by year

AstraZeneca (AZN) free cash flow by fiscal year

| Fiscal year | Free cash flow | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $8.67B | 19.2% up | Dec 31, 2025 |
| 2024 | $7.28B | 10.8% up | Dec 31, 2024 |
| 2023 | $6.57B | 9.3% down | Dec 31, 2023 |
| 2022 | $7.24B | — | Dec 31, 2022 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

### How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

### Free cash flow at health care companies of similar size

Free cash flow of AstraZeneca and comparable companies

| Company | Free cash flow | Fiscal year |
| --- | --- | --- |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/free-cash-flow) | $12.36B | 2025 |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/free-cash-flow) | $16.08B | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/free-cash-flow) | $15.24B | 2025 |
| AstraZeneca AZN | $8.67B | 2025 |
| [Thermo Fisher Scientific TMO](https://funkfolio.com/stock/TMO/free-cash-flow) | $6.29B | 2025 |
| [Amgen AMGN](https://funkfolio.com/stock/AMGN/free-cash-flow) | $8.10B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### AstraZeneca, figure by figure

- [AstraZeneca market cap](https://funkfolio.com/stock/AZN/market-cap)
- [AstraZeneca revenue](https://funkfolio.com/stock/AZN/revenue)
- [AstraZeneca earnings](https://funkfolio.com/stock/AZN/earnings)
- [AstraZeneca earnings per share (EPS)](https://funkfolio.com/stock/AZN/eps)
- [AstraZeneca P/E ratio](https://funkfolio.com/stock/AZN/pe-ratio)
- [AstraZeneca P/S ratio](https://funkfolio.com/stock/AZN/ps-ratio)
- [AstraZeneca P/B ratio](https://funkfolio.com/stock/AZN/pb-ratio)
- [AstraZeneca operating margin](https://funkfolio.com/stock/AZN/operating-margin)
- [AstraZeneca dividend](https://funkfolio.com/stock/AZN/dividend)
- [AstraZeneca shares outstanding](https://funkfolio.com/stock/AZN/shares-outstanding)
- [AstraZeneca total debt](https://funkfolio.com/stock/AZN/total-debt)
- [AstraZeneca cash on hand](https://funkfolio.com/stock/AZN/cash)
- [AstraZeneca total assets](https://funkfolio.com/stock/AZN/total-assets)
- [AstraZeneca return on equity (ROE)](https://funkfolio.com/stock/AZN/roe)
- [AstraZeneca return on invested capital (ROIC)](https://funkfolio.com/stock/AZN/roic)

[AstraZeneca (AZN) overview: price, valuation and scorecard](https://funkfolio.com/stock/AZN) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### AstraZeneca free cash flow: questions and answers

**What is AstraZeneca's free cash flow?**

AstraZeneca (AZN) generated free cash flow of $8.67B in fiscal 2025 (the year ended December 31, 2025). That is 19.2% higher than the $7.28B of fiscal 2024.

**What are the highest and lowest free cash flow figures on record for AstraZeneca?**

Across the 4 fiscal years on record (2022–2025), the highest was $8.67B in fiscal 2025 and the lowest $6.57B in fiscal 2023.

**How is AstraZeneca's free cash flow calculated?**

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For AstraZeneca it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: free cash flow

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- [How a DCF valuation works, and why inputs swing it](https://funkfolio.com/learn/stocks/dcf-valuation)

  A discounted cash flow (DCF) valuation estimates what a business is worth today by forecasting the cash it will produce and discounting each year's cash back at a required rate of return. Because most of the value lies far in the future, a one-point change in growth or discount rate can move the answer by a quarter.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “AstraZeneca (AZN) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/AZN/free-cash-flow

Underlying data: Yahoo Finance.
